Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Artificial Intelligence-powered Approach to Precision Immunotherapy of Human Arthritis - A Double-blind, Randomized, Placebo-controlled Clinical Trial

NCT07013110 is registered in ClinicalTrials.gov with Prof Salvatore Albani as lead sponsor.

NCT NCT07013110
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07013110 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Artificial Intelligence-powered Approach to Precision Immunotherapy of Human Arthritis - A Double-blind, Randomized, Placebo-controlled Clinical Trial
Lead sponsor
Prof Salvatore Albani
Phase
Phase 2
Overall status
Recruiting
Start date
June 18, 2025
Completion date
November 30, 2028
Enrollment
124 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis (ra), rheumatology